Regeneron Pharmaceuticals Pre-Paid Expenses 2010-2024 | REGN

Regeneron Pharmaceuticals pre-paid expenses for the quarter ending September 30, 2024 were $0.412B, a 28.31% decline year-over-year.

  • Regeneron Pharmaceuticals pre-paid expenses for 2023 were $0.387B, a 5.98% decline from 2022.
  • Regeneron Pharmaceuticals pre-paid expenses for 2022 were $0.411B, a 23.71% increase from 2021.
  • Regeneron Pharmaceuticals pre-paid expenses for 2021 were $0.332B, a 106.72% increase from 2020.

Regeneron Pharmaceuticals Pre-Paid Expenses 2010-2024 | REGN

  • Regeneron Pharmaceuticals pre-paid expenses for 2023 were $0.387B, a 5.98% decline from 2022.
  • Regeneron Pharmaceuticals pre-paid expenses for 2022 were $0.411B, a 23.71% increase from 2021.
  • Regeneron Pharmaceuticals pre-paid expenses for 2021 were $0.332B, a 106.72% increase from 2020.